C. Barazzone et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN ACUTE HYPEROXIC MOUSE LUNG INJURY, The Journal of clinical investigation, 98(12), 1996, pp. 2666-2673
Hyperoxia-induced lung disease is associated with prominent intraalveo
lar fibrin deposition, Fibrin turnover is tightly regulated by the con
certed action of proteases and antiproteases, and inhibition of plasmi
n-mediated proteolysis could account for fibrin accumulation in lung a
lveoli. We show here that lungs of mice exposed to hyperoxia overprodu
ce plasminogen activator inhibitor-1 (PAI-1), and that PAI-1 upregulat
ion impairs fibrinolytic activity in the alveolar compartment. To expl
ore whether increased PAI-1 production is a causal or only a correlati
ve event for impaired intraalveolar fibrinolysis and the development o
f hyaline membrane disease, we studied mice genetically deficient in P
AI-1. We found that these mice fail to develop intraalveolar fibrin de
posits in response to hyperoxia and that they are more resistant to th
e lethal effects of hyperoxic stress, These observations provide clear
and novel evidence for the pathogenic contribution of PAI-1 in the de
velopment of hyaline membrane disease. They identify PAI-1 as a major
deleterious mediator of hyperoxic lung injury.